CY2023020I1 - Συνθεσεις mycoplasma bovis - Google Patents
Συνθεσεις mycoplasma bovisInfo
- Publication number
- CY2023020I1 CY2023020I1 CY2023020C CY2023020C CY2023020I1 CY 2023020 I1 CY2023020 I1 CY 2023020I1 CY 2023020 C CY2023020 C CY 2023020C CY 2023020 C CY2023020 C CY 2023020C CY 2023020 I1 CY2023020 I1 CY 2023020I1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions
- mycoplasma bovis
- bovis
- mycoplasma
- bovis compositions
- Prior art date
Links
- 241001138504 Mycoplasma bovis Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562205125P | 2015-08-14 | 2015-08-14 | |
PCT/US2016/046572 WO2017030901A1 (en) | 2015-08-14 | 2016-08-11 | Mycoplasma bovis compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
CY2023020I2 CY2023020I2 (el) | 2024-02-16 |
CY2023020I1 true CY2023020I1 (el) | 2024-02-16 |
Family
ID=56800367
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20221100762T CY1125699T1 (el) | 2015-08-14 | 2022-12-02 | Συνθεσεις mycoplasma bovis |
CY2023020C CY2023020I1 (el) | 2015-08-14 | 2023-10-03 | Συνθεσεις mycoplasma bovis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20221100762T CY1125699T1 (el) | 2015-08-14 | 2022-12-02 | Συνθεσεις mycoplasma bovis |
Country Status (23)
Country | Link |
---|---|
US (2) | US11389518B2 (el) |
EP (2) | EP4137152A1 (el) |
JP (1) | JP6675484B2 (el) |
CN (3) | CN108135989B (el) |
AU (2) | AU2016307935B2 (el) |
BR (1) | BR112018002919B1 (el) |
CA (1) | CA2995101A1 (el) |
CY (2) | CY1125699T1 (el) |
DK (1) | DK3334454T3 (el) |
ES (1) | ES2933623T3 (el) |
FI (1) | FI3334454T3 (el) |
FR (1) | FR23C1037I1 (el) |
HK (1) | HK1251478A1 (el) |
HR (1) | HRP20221440T1 (el) |
HU (2) | HUE060545T2 (el) |
LT (1) | LT3334454T (el) |
MX (1) | MX2018001841A (el) |
NL (1) | NL301244I2 (el) |
PL (1) | PL3334454T3 (el) |
PT (1) | PT3334454T (el) |
SI (1) | SI3334454T1 (el) |
WO (1) | WO2017030901A1 (el) |
ZA (1) | ZA201800956B (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
CN111471695A (zh) * | 2020-05-11 | 2020-07-31 | 吉林农业大学 | 牛支原体免疫磁珠的制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
EP0575491B1 (en) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
JPH07507854A (ja) | 1991-12-23 | 1995-08-31 | ツォッヒェ,ミヒャエル | 油除去装置を備えたエンジン |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
ATE364090T1 (de) | 1996-02-28 | 2007-06-15 | Bayer Healthcare Ag | Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen |
BR9712852A (pt) | 1996-10-23 | 1999-11-16 | Univ Pennsylvania | Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
WO1999043839A1 (en) | 1998-02-27 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
KR100625385B1 (ko) | 1998-03-13 | 2006-09-18 | 와이어쓰 | 폴리뉴클레오티드 조성물, 이의 제조방법, 및 용도 |
BR9914160A (pt) | 1998-09-30 | 2001-06-26 | American Cyanamid Co | Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante |
EP1229929A2 (en) | 1999-11-08 | 2002-08-14 | Biomune | VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
US6548069B2 (en) | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
GB0110851D0 (en) | 2001-05-03 | 2001-06-27 | Mini Agriculture & Fisheries | Vaccine |
CN1541111A (zh) | 2001-06-07 | 2004-10-27 | ���Ͽع�����˾ | 作为佐剂的霍乱全毒素的突变形式 |
EP1404368B1 (en) | 2001-06-07 | 2009-12-09 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
US20030147914A1 (en) | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
WO2005048957A2 (en) | 2003-02-20 | 2005-06-02 | Therion Biologics Corporation | Novel insertion sites in pox vectors |
US20090068231A1 (en) * | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
UY31437A1 (es) | 2007-10-29 | 2009-05-29 | Vacuna de mycoplasma bovis y métodos de uso de la misma | |
EP2320943B1 (en) | 2008-07-03 | 2016-02-17 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
EP2362780B1 (en) | 2008-10-31 | 2019-12-25 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
MX2011007606A (es) * | 2009-02-20 | 2011-08-08 | Australian Poultry Crc Pty Ltd | Vacunas atenuadas vivas. |
UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
-
2016
- 2016-08-11 WO PCT/US2016/046572 patent/WO2017030901A1/en active Application Filing
- 2016-08-11 FI FIEP16757118.1T patent/FI3334454T3/fi active
- 2016-08-11 JP JP2018527845A patent/JP6675484B2/ja active Active
- 2016-08-11 HU HUE16757118A patent/HUE060545T2/hu unknown
- 2016-08-11 DK DK16757118.1T patent/DK3334454T3/da active
- 2016-08-11 PL PL16757118.1T patent/PL3334454T3/pl unknown
- 2016-08-11 PT PT167571181T patent/PT3334454T/pt unknown
- 2016-08-11 AU AU2016307935A patent/AU2016307935B2/en active Active
- 2016-08-11 LT LTEPPCT/US2016/046572T patent/LT3334454T/lt unknown
- 2016-08-11 ES ES16757118T patent/ES2933623T3/es active Active
- 2016-08-11 EP EP22200449.1A patent/EP4137152A1/en active Pending
- 2016-08-11 EP EP16757118.1A patent/EP3334454B1/en active Active
- 2016-08-11 MX MX2018001841A patent/MX2018001841A/es unknown
- 2016-08-11 US US15/751,293 patent/US11389518B2/en active Active
- 2016-08-11 CN CN201680047885.8A patent/CN108135989B/zh active Active
- 2016-08-11 CA CA2995101A patent/CA2995101A1/en active Pending
- 2016-08-11 HR HRP20221440TT patent/HRP20221440T1/hr unknown
- 2016-08-11 SI SI201631651T patent/SI3334454T1/sl unknown
- 2016-08-11 BR BR112018002919-0A patent/BR112018002919B1/pt active IP Right Grant
- 2016-08-11 CN CN202210776436.4A patent/CN115141773A/zh active Pending
- 2016-08-11 CN CN202210776410.XA patent/CN115141772A/zh active Pending
-
2018
- 2018-02-13 ZA ZA2018/00956A patent/ZA201800956B/en unknown
- 2018-08-28 HK HK18111050.4A patent/HK1251478A1/zh unknown
-
2022
- 2022-06-06 US US17/833,002 patent/US20220296694A1/en active Pending
- 2022-09-15 AU AU2022231761A patent/AU2022231761A1/en active Pending
- 2022-12-02 CY CY20221100762T patent/CY1125699T1/el unknown
-
2023
- 2023-09-29 NL NL301244C patent/NL301244I2/nl unknown
- 2023-10-02 HU HUS2300032C patent/HUS2300032I1/hu unknown
- 2023-10-03 CY CY2023020C patent/CY2023020I1/el unknown
- 2023-10-18 FR FR23C1037C patent/FR23C1037I1/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3361870T3 (da) | Fungicidsammensætninger | |
DK3215173T3 (da) | Glycopeptidsammensætninger | |
MA41976A (fr) | Composition lubrifiante ultra-fluide | |
DK3040326T3 (da) | Haloolefin-baseret sammensætning | |
DK3334726T3 (da) | Plinabulinsammensætninger | |
FR3034100B1 (fr) | Composition lubrifiante | |
DK3250182T3 (da) | Dispergible sammensætninger | |
FR3024363B1 (fr) | Composition thermogelifiable | |
DK3528902T3 (da) | Ringegelsammensætning | |
CL2017000639A1 (es) | Composición | |
DK3331498T3 (da) | Nasalsammensætning | |
FR3020948B1 (fr) | Composition antimicrobienne | |
CY2023020I1 (el) | Συνθεσεις mycoplasma bovis | |
DK3316857T3 (da) | Multifasiske sammensætninger | |
DK3393254T3 (da) | Sammensætning | |
DK3200827T3 (da) | Sammensætninger | |
DK3528791T3 (da) | Dispergible sammensætninger | |
DK3416502T3 (da) | Glykæmisk-reducerende sammensætning | |
DK3337322T3 (da) | Fungicidsammensætninger | |
DK3317458T3 (da) | Mineralsammensætninger | |
BR112017016240A2 (pt) | composição | |
DK3217964T3 (da) | Sammensætning | |
FR3025106B1 (fr) | Composition antimicrobienne | |
FR3019552B1 (fr) | Composition filmogene | |
DK3347444T3 (da) | Fedtsammensætninger |